Evidence map›Paper›PMID 38848103›Full record

ArticleJournal of medicinal chemistry2024

Fast Quantitative Validation of 3D Models of Low-Affinity Protein-Ligand Complexes by STD NMR Spectroscopy.

Ridvan Nepravishta, Jonathan Ramírez-Cárdenas, Gabriel Rocha, Samuel Walpole, Thomas Hicks, Serena Monaco, Juan C Muñoz-García, Jesús Angulo

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ridvan NepravishtaSchool of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, U.K.
Jonathan Ramírez-CárdenasInstitute for Chemical Research (IIQ), CSIC - University of Seville, 49 Américo Vespucio, 41092 Seville, Spain.
Gabriel RochaInstitute for Chemical Research (IIQ), CSIC - University of Seville, 49 Américo Vespucio, 41092 Seville, Spain.ORCID 0009-0004-5673-5943
Samuel WalpoleSchool of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, U.K.
Thomas HicksSchool of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, U.K.
Serena MonacoSchool of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, U.K.ORCID 0000-0001-9396-7568
Juan C Muñoz-GarcíaInstitute for Chemical Research (IIQ), CSIC - University of Seville, 49 Américo Vespucio, 41092 Seville, Spain.ORCID 0000-0003-2246-3236
Jesús AnguloSchool of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, U.K.ORCID 0000-0001-7250-5639

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-affinity protein-ligand interactions are important for many biological processes, including cell communication, signal transduction, and immune responses. Structural characterization of these complexes is also critical for the development of new drugs through fragment-based drug discovery (FBDD), but it is challenging due to the low affinity of fragments for the binding site. Saturation transfer difference (STD) NMR spectroscopy has revolutionized the study of low-affinity receptor-ligand interactions enabling binding detection and structural characterization. Comparison of relaxation and exchange matrix calculations with

Indexed as

ProteinsBinding SitesDrug DiscoveryHumansLigandsMagnetic Resonance SpectroscopyModels, MolecularMolecular Dynamics SimulationNuclear Magnetic Resonance, BiomolecularProtein BindingProtein ConformationLigandsProteins

Identifiers

PMID38848103
PMCPMC11215723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.